Last reviewed · How we verify
NCT05051176
Prevalence of Diastasis m. Rectus Abdominis in Postpartum Women
trial testing 2D usg and 3D/4D usg in Diastasis of m. Rectus Abdominis in 150 participants. Completed in 23 May 2022.
28 April 2022
Quick facts
| Lead sponsor | Pavol Jozef Safarik University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 8 April 2021 |
| Primary completion | 28 April 2022 |
| Estimated completion | 23 May 2022 |
| Sites | 1 location across Slovakia |
Drugs / interventions tested
- 2D usg and 3D/4D usg
Conditions studied
- Diastasis of m. Rectus Abdominis — all drugs for Diastasis of m. Rectus Abdominis →
Sponsor
Pavol Jozef Safarik University
Who can join
Adults 18 to 40, female only, with Diastasis of m. Rectus Abdominis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will evaluate the prevalence of diastasis m. rectus abdominis after delivery. Relationship of Diastasis Recti Abdominis with urine leakage, pelvic floor muscle function and morphometry in postpartum women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05051176
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Pavol Jozef Safarik University trials
Trials by the same sponsor.
- NCT07491068 — The Accuracy and Efficacy of Large Language Model Written Hospital Course Summaries · NA · not yet recruiting
- NCT06358196 — Complex Exploratory Study of Alcohol-Associated Hepatitis · not yet recruiting
- NCT03916666 — Chronic Low Back Pain - Epiduroscopy Treatment · unknown
- NCT03105232 — Opioid-Redox Study · unknown
- NCT03915301 — Effective Postoperative Pain Treatment After Sternotomy. Comparison of the Erector Spinae Plane Block vs Conventional Op · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05051176 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pavol Jozef Safarik University
- Last refreshed: 7 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05051176.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing